Literature DB >> 28813035

Bladder cancer: The promise of liquid biopsy ctDNA analysis.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28813035     DOI： 10.1038/nrurol.2017.138

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.

Authors:  Gillian Vandekerkhove; Tilman Todenhöfer; Matti Annala; Werner J Struss; Amanda Wong; Kevin Beja; Elie Ritch; Sonal Brahmbhatt; Stanislav V Volik; Jörg Hennenlotter; Matti Nykter; Kim N Chi; Scott North; Arnulf Stenzl; Colin C Collins; Bernhard J Eigl; Peter C Black; Alexander W Wyatt
Journal:  Clin Cancer Res       Date:  2017-07-31       Impact factor: 12.531
  1 in total
  1 in total

Review 1.  Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring.

Authors:  Iris Lodewijk; Marta Dueñas; Carolina Rubio; Ester Munera-Maravilla; Cristina Segovia; Alejandra Bernardini; Alicia Teijeira; Jesús M Paramio; Cristian Suárez-Cabrera
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.